title: The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.
abstract: BACKGROUND
  The etiology of inflammatory bowel disease (IBD) is not clear and cytomegalovirus (CMV) infection is often associated with IBD patients. The etiologic link between IBD and CMV infection needs to be studied. The objective of the present study is to investigate the prevalence and risk factors of CMV in a cohort of IBD patients from Central China.
  
  
  METHODS
  Two hundred and twenty six IBD patients (189 ulcerative colitis (UC) and 37 patients with Crohn's disease (CD)), and 290 age and sex matched healthy controls were recruited. CMV DNA was detected by nested PCR, while serum anti-CMV IgG and anti-CMV IgM was determined by ELISAs. Colonoscopy/enteroscopy with biopsy of diseased tissues and subsequent H&E stain were then conducted in IBD patients with positive anti-CMV IgM. Finally, we analyzed the prevalence and clinical risk factors of CMV infection in IBD patients.
  
  
  RESULTS
  The prevalence of CMV DNA and anti-CMV IgG positive rate in IBD patients were 84.07% and 76.11%, respectively, higher than those in healthy controls (59.66% and 50.69%, respectively, P < 0.05), However, anti-CMV IgM positive rate was no different with healthy controls (1.77% vs 0.34%, P = 0.235). In univariate analysis of risk factors, the recent use of corticosteroid was associated with increase of CMV DNA and IgM positive rate in UC (P = 0.035 and P = 0.015, respectively), aminosalicylic acid drug therapy was correlated with positivity of CMV DNA and IgG in UC and CMV DNA in CD (P = 0.041, P < 0.001 and P = 0.014, respectively), the treatment of immunosuppresent was correlated with CMV IgM (P < 0.001). Furthermore, patients with severe UC were significantly associated with CMV DNA and IgM (P = 0.048 and P = 0.031, respectively). Malnutrition (albumin < 35 G/L) was also found to be related with CMV recent infection (P = 0.031). In multivariate analysis of risk factors in UC, pancolitis was significantly associated with CMV DNA positivity (P = 0.001). Severe UC and pancolitis seemed to be related with IgG positivity. For CD, there was just single factor associated with CMV positive in each group, multivariate analysis was unnecessary.
  
  
  CONCLUSIONS
  CMV positive rate in IBD patients was significantly higher, than in healthy controls. The use of aminosalicylic acid, corticosteroid, immunosuppressants, pancolitis and severe IBD patients seemed to be more susceptible to CMV infection in univariate analysis of risk factors. However, no risk factor was found to be significantly correlated with CMV infection in multivariate analysis of risk factors.
authors: Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Donghu Road 169, Wuhan 430071, PR of China.
authors: Fengming
authors: F
authors: Yi
authors: Jie
authors: J
authors: Zhao
authors: Rishi Vishal
authors: RV
authors: Luckheeram
authors: Yuan
authors: Y
authors: Lei
authors: Changgao
authors: C
authors: Wang
authors: Sha
authors: S
authors: Huang
authors: Lu
authors: L
authors: Song
authors: Wei
authors: W
authors: Wang
authors: Bing
authors: B
authors: Xia
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D015331:Cohort Studies; D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000821:virology*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D055815:Young Adult
references: Aliment Pharmacol Ther. 2004 Dec;20(11-12):1323-7
references: 15606394
references: Gastroenterology. 1976 Mar;70(3):439-44
references: 1248701
references: Am J Gastroenterol. 2001 Mar;96(3):895-9
references: 11280572
references: Am J Gastroenterol. 2006 Dec;101(12):2857-65
references: 17026558
references: J Clin Virol. 2008 Oct;43(2):180-3
references: 18614396
references: Inflamm Bowel Dis. 2006 Mar;12(3):212-7
references: 16534423
references: Clin Infect Dis. 1997 Jan;24(1):52-6
references: 8994755
references: J Med Microbiol. 2004 Nov;53(Pt 11):1155-1160
references: 15496396
references: Dig Dis Sci. 2010 Apr;55(4):1059-65
references: 20112061
references: Clin Microbiol Rev. 1998 Jul;11(3):533-54
references: 9665982
references: Gastroenterol Clin Biol. 2007 Mar;31(3):292-6
references: 17396088
references: J Med Virol. 2010 Oct;82(10):1694-700
references: 20827767
references: Clin Microbiol Rev. 2002 Oct;15(4):680-715
references: 12364375
references: Dig Dis Sci. 2009 Nov;54(11):2456-62
references: 19093204
references: Arch Pathol Lab Med. 2005 Feb;129(2):200-4
references: 15679421
references: Transfusion. 2001 Oct;41(10):1249-57
references: 11606824
references: Inflamm Bowel Dis. 2006 Sep;12(9):879-84
references: 16954807
references: Am J Pathol. 2009 Nov;175(5):2034-42
references: 19815702
references: Br Med J. 1955 Oct 29;2(4947):1041-8
references: 13260656
references: Am J Gastroenterol. 2001 Jul;96(7):2137-42
references: 11467645
references: Lancet. 2002 Nov 16;360(9345):1557-63
references: 12443594
references: Am J Gastroenterol. 1986 Oct;81(10):944-50
references: 3020973
references: Hong Kong Med J. 1998 Dec;4(4):437-439
references: 11830711